美国 · 股市与财经 · Morningstar
Celaid Therapeutics Completes Second Close of Series B Financing Round
TOKYO, Oct. 4, 2026 /PRNewswire/ -- Celaid Therapeutics Inc. (Head Office: Bunkyo-ku, Tokyo, Japan; President and CEO: Nobuyuki Arakawa; "Celaid") today announced the completion…
在 Morningstar 阅读全文 登录后可收藏MediaNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.morningstar.com)





